These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 28385079)
21. Anti-Thrombin, Anti-Adhesive, Anti-Migratory, and Anti-Proliferative Activities of Sulfated Galactans from the Tropical Green Seaweed, Mendes Marques ML; Presa FB; Viana RLS; Costa MSSP; Amorim MOR; Bellan DL; Alves MGCF; Costa LS; Trindade ES; Rocha HAO Mar Drugs; 2018 Dec; 17(1):. PubMed ID: 30577590 [TBL] [Abstract][Full Text] [Related]
22. Trefoil factors: tumor progression markers and mitogens via EGFR/MAPK activation in cholangiocarcinoma. Kosriwong K; Menheniott TR; Giraud AS; Jearanaikoon P; Sripa B; Limpaiboon T World J Gastroenterol; 2011 Mar; 17(12):1631-41. PubMed ID: 21472131 [TBL] [Abstract][Full Text] [Related]
23. Angiotensin II promotes smooth muscle cell proliferation and migration through release of heparin-binding epidermal growth factor and activation of EGF-receptor pathway. Yang X; Zhu MJ; Sreejayan N; Ren J; Du M Mol Cells; 2005 Oct; 20(2):263-70. PubMed ID: 16267402 [TBL] [Abstract][Full Text] [Related]
24. 22-oxa-1,25-dihydroxyvitamin D3 efficiently inhibits tumor growth in inoculated mice and primary histoculture of cholangiocarcinoma. Seubwai W; Wongkham C; Puapairoj A; Okada S; Wongkham S Cancer; 2010 Dec; 116(23):5535-43. PubMed ID: 20681031 [TBL] [Abstract][Full Text] [Related]
25. ZD1839 (IRESSA) stabilizes p27Kip1 and enhances radiosensitivity in cholangiocarcinoma cell lines. Yabuuchi S; Katayose Y; Oda A; Mizuma M; Shirasou S; Sasaki T; Yamamoto K; Oikawa M; Rikiyama T; Onogawa T; Yoshida H; Ohtuska H; Motoi F; Egawa S; Unno M Anticancer Res; 2009 Apr; 29(4):1169-80. PubMed ID: 19414361 [TBL] [Abstract][Full Text] [Related]
26. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas. Li B; Chang CM; Yuan M; McKenna WG; Shu HK Cancer Res; 2003 Nov; 63(21):7443-50. PubMed ID: 14612544 [TBL] [Abstract][Full Text] [Related]
27. Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma. Ewald F; Grabinski N; Grottke A; Windhorst S; Nörz D; Carstensen L; Staufer K; Hofmann BT; Diehl F; David K; Schumacher U; Nashan B; Jücker M Int J Cancer; 2013 Nov; 133(9):2065-76. PubMed ID: 23588885 [TBL] [Abstract][Full Text] [Related]
28. Growth hormone alters epidermal growth factor receptor binding affinity via activation of extracellular signal-regulated kinases in 3T3-F442A cells. Huang Y; Chang Y; Wang X; Jiang J; Frank SJ Endocrinology; 2004 Jul; 145(7):3297-306. PubMed ID: 15070853 [TBL] [Abstract][Full Text] [Related]
29. The proliferative effects of Pyropia yezoensis peptide on IEC-6 cells are mediated through the epidermal growth factor receptor signaling pathway. Lee MK; Kim IH; Choi YH; Choi JW; Kim YM; Nam TJ Int J Mol Med; 2015 Apr; 35(4):909-14. PubMed ID: 25716690 [TBL] [Abstract][Full Text] [Related]
30. Suppression of Cholangiocarcinoma Cell Growth and Proliferation by Atractylodes lancea (Thunb) DC. through ERK-Signaling Cascade. Martviset P; Panrit L; Chantree P; Muhamad P; Na-Bangchang K Asian Pac J Cancer Prev; 2021 Nov; 22(11):3633-3640. PubMed ID: 34837922 [TBL] [Abstract][Full Text] [Related]
31. Lobaplatin induces apoptosis and arrests cell cycle progression in human cholangiocarcinoma cell line RBE. Wang Z; Tang X; Zhang Y; Qi R; Li Z; Zhang K; Liu Z; Yang X Biomed Pharmacother; 2012 Apr; 66(3):161-6. PubMed ID: 22425181 [TBL] [Abstract][Full Text] [Related]
36. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells. Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913 [TBL] [Abstract][Full Text] [Related]
37. Amplified in breast cancer 1 enhances human cholangiocarcinoma growth and chemoresistance by simultaneous activation of Akt and Nrf2 pathways. Chen Q; Li W; Wan Y; Xia X; Wu Q; Chen Y; Lai Z; Yu C; Li W Hepatology; 2012 Jun; 55(6):1820-9. PubMed ID: 22213475 [TBL] [Abstract][Full Text] [Related]
38. The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer. Raben D; Helfrich B; Chan DC; Ciardiello F; Zhao L; Franklin W; Barón AE; Zeng C; Johnson TK; Bunn PA Clin Cancer Res; 2005 Jan; 11(2 Pt 1):795-805. PubMed ID: 15701870 [TBL] [Abstract][Full Text] [Related]
39. Hydroxytyrosol inhibits cholangiocarcinoma tumor growth: an in vivo and in vitro study. Li S; Han Z; Ma Y; Song R; Pei T; Zheng T; Wang J; Xu D; Fang X; Jiang H; Liu L Oncol Rep; 2014 Jan; 31(1):145-52. PubMed ID: 24247752 [TBL] [Abstract][Full Text] [Related]
40. Characterization of EGFR family gene aberrations in cholangiocarcinoma. Yang X; Wang W; Wang C; Wang L; Yang M; Qi M; Su H; Sun X; Liu Z; Zhang J; Qin X; Han B Oncol Rep; 2014 Aug; 32(2):700-8. PubMed ID: 24927194 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]